or Try an Advanced Search...

    Technical Analysis for ALDX - Aldeyra Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 3.93 -0.25% -0.01
    ALDX closed down 0.25 percent on Friday, April 26, 2024, on 43 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 2
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Flat
    Historical ALDX trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Outside Day Range Expansion -0.25%
    Wide Bands Range Expansion -0.25%
    Oversold Stochastic Weakness -0.25%
    NR7 Range Contraction -0.25%
    Narrow Range Bar Range Contraction -0.25%
    Stochastic Reached Oversold Weakness -0.25%
    Wide Bands Range Expansion -0.25%
    Older End-of-Day Signals for ALDX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 10 DMA about 13 hours ago
    Fell Below Previous Day's Low about 15 hours ago
    60 Minute Opening Range Breakdown about 16 hours ago
    Down 2 % about 16 hours ago
    10 DMA Resistance about 17 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ALDX Chart by TradingView
    Basic chart:

    Profile

    Aldeyra Therapeutics, Inc. (Aldeyra) is a biotechnology company. The Company is focused primarily on the development of products to treat immune-mediated, inflammatory, orphan, and other diseases that are thought to be related to a naturally occurring toxic chemical species known as free aldehydes. The Company is developing NS2. NS2 is a product candidate that is designed to trap and allow for disposal of free aldehydes, for the treatment of diseases, which include Sjogren-Larsson Syndrome (SLS), discoid lupus, acute anterior uveitis and ocular rosacea with meibomian gland dysfunction. Aldeyra is also developing aldehyde traps distinct from NS2. As of April 7, 2014, it had evaluated NS2 in a Phase I clinical trial in 48 volunteers.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Disease Organ Systems Autoimmune Disease Rare Diseases Dysfunction Lupus Syndromes Inflammatory Uveitis Rosacea Systemic Lupus Erythematosus Discoid Lupus Meibomian Gland Ns2

    Is ALDX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day
    Apr 22 Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?
    Apr 18 Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024
    Apr 6 Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why
    Apr 5 Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
    Apr 4 Aldeyra gains as Perceptive Advisors boosts stake
    Apr 4 Health Care Roundup: Market Talk
    Apr 4 Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
    Apr 3 Aldeyra's Dry Eye Disease Drug May Be on Path for FDA Approval
    Apr 3 Aldeyra gains as Oppenheimer upgrades on revised plans for lead asset
    See more ALDX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.97
    52 Week Low 1.42
    Average Volume 626,889
    200-Day Moving Average 4.45
    50-Day Moving Average 3.64
    20-Day Moving Average 4.08
    10-Day Moving Average 3.95
    Average True Range 0.27
    RSI (14) 52.83
    ADX 26.09
    +DI 26.19
    -DI 17.59
    Chandelier Exit (Long, 3 ATRs) 4.17
    Chandelier Exit (Short, 3 ATRs) 3.68
    Upper Bollinger Bands 4.76
    Lower Bollinger Band 3.40
    Percent B (%b) 0.39
    BandWidth 33.43
    MACD Line 0.10
    MACD Signal Line 0.15
    MACD Histogram -0.0493
    Fundamentals Value
    Market Cap 231.17 Million
    Num Shares 58.8 Million
    EPS -0.78
    Price-to-Earnings (P/E) Ratio -5.04
    Price-to-Sales 0.00
    Price-to-Book 1.58
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.15
    Resistance 3 (R3) 4.14 4.06 4.11
    Resistance 2 (R2) 4.06 4.00 4.06 4.10
    Resistance 1 (R1) 3.99 3.97 3.95 4.00 4.09
    Pivot Point 3.91 3.91 3.89 3.92 3.91
    Support 1 (S1) 3.85 3.86 3.81 3.86 3.77
    Support 2 (S2) 3.77 3.82 3.77 3.76
    Support 3 (S3) 3.70 3.77 3.75
    Support 4 (S4) 3.71